Crossmark

Development of Romiplostim for Treatment of Primary Immune Thrombocytopenia From a Pharmacokinetic and Pharmacodynamic Perspective

Crossref DOI link: https://doi.org/10.1007/s40262-016-0382-7

Published Online: 2016-04-07

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Bing-Bing

Doshi, Sameer

Arkam, Karen

Franklin, Janet

Chow, Andrew T.
Funding

Funding for this research was provided by:

Amgen
License Information

Text and Data Mining valid from 2016-04-07